Fig. 8

(A) Barplot of immune cell proportions calculated by the CIBERSORT algorithm for the high-risk group in TCGA. (B) Barplot of immune cell proportions calculated by the CIBERSORT algorithm for the low-risk group in TCGA. (C) The difference in M2 cell proportions between high-risk and low-risk groups. (D) The difference in lymphocyte proportions between high-risk and low-risk groups. (E) Comparison of clinical stage differences between high-risk and low-risk groups. (F) Analysis of the difference in immunophenotype score (IPS) between high-risk and low-risk groups. (G–K) Drug sensitivity analysis between high-risk and low-risk groups.